User contributions for Lazy

26 March 2024

• 00:5800:58, 26 March 2024 diff hist +3,784‎ Accutane ‎No edit summary
• 00:5500:55, 26 March 2024 diff hist +2,165‎ Chloroquine ‎No edit summary
• 00:5100:51, 26 March 2024 diff hist −10‎ Category:Repurposed Drugs ‎ →‎List of Repurposed Drugs
• 00:5000:50, 26 March 2024 diff hist +2,826‎ Fish oil ‎No edit summary
• 00:4800:48, 26 March 2024 diff hist +4,041‎ Ellagic acid ‎No edit summary
• 00:4100:41, 26 March 2024 diff hist 0‎ Template:TreatmentInfo ‎No edit summary
• 00:3900:39, 26 March 2024 diff hist +24‎ Template:TreatmentInfo ‎No edit summary
• 00:3700:37, 26 March 2024 diff hist +206‎ N Category:Repurposed Drugs ‎ Created page with "== List of Repurposed Drugs == {{#ask: Category:Nutraceuticals and Herbals |?Has treatment name=Drug Name |?Has Usefulness Rating=Usefulness Rating |?Has Toxicity Level=Toxicity Level |format=table }}"
• 00:2800:28, 26 March 2024 diff hist +3,377‎ N MGMT ‎ Created page with "== The role of MGMT == � A significant advance in determining which patients will benefit from Temodar was reported by the same research group that reported the definitive trial combining Temodar with radiation. Tumor specimens from the patients in that trial were tested for the level of activation of a specific gene involved in resistance to alkylating chemotherapy (which includes temozolomide and the nitrosoureas, BCNU, CCNU, and ACNU). More specifically, there is an..."
• 00:2800:28, 26 March 2024 diff hist −1‎ Main Page ‎No edit summary
• 00:2700:27, 26 March 2024 diff hist +3,377‎ N Full text ‎ Created page with "== The role of MGMT == � A significant advance in determining which patients will benefit from Temodar was reported by the same research group that reported the definitive trial combining Temodar with radiation. Tumor specimens from the patients in that trial were tested for the level of activation of a specific gene involved in resistance to alkylating chemotherapy (which includes temozolomide and the nitrosoureas, BCNU, CCNU, and ACNU). More specifically, there is an..." current
• 00:2600:26, 26 March 2024 diff hist +465‎ Main Page ‎No edit summary

25 March 2024

• 23:1423:14, 25 March 2024 diff hist +10,789‎ Main Page ‎No edit summary
• 23:0923:09, 25 March 2024 diff hist −4‎ Curcumin ‎No edit summary
• 23:0823:08, 25 March 2024 diff hist +1,854‎ Curcumin ‎No edit summary
• 23:0323:03, 25 March 2024 diff hist +113‎ Template:TreatmentInfo ‎No edit summary
• 22:5722:57, 25 March 2024 diff hist +4,472‎ BCNU (Carmustine) and Gliadel (Carmustine Wafers) ‎No edit summary
• 22:5522:55, 25 March 2024 diff hist +110‎ Template:TreatmentInfo ‎No edit summary
• 20:4520:45, 25 March 2024 diff hist −85‎ Angiotensin-II Receptor Blockers (ARB) ‎No edit summary
• 20:1020:10, 25 March 2024 diff hist +145‎ Category:Hormones ‎No edit summary
• 19:5819:58, 25 March 2024 diff hist −114‎ Gleevec (Imatinib) ‎No edit summary
• 19:5519:55, 25 March 2024 diff hist −46‎ Category:Other Chemotherapy and Cancer Drugs ‎No edit summary
• 19:5419:54, 25 March 2024 diff hist 0‎ Template:TreatmentInfo ‎No edit summary Tag: Manual revert
• 19:5119:51, 25 March 2024 diff hist 0‎ Template:TreatmentInfo ‎No edit summary Tag: Reverted
• 19:5019:50, 25 March 2024 diff hist −98‎ Category:Other Chemotherapy and Cancer Drugs ‎No edit summary
• 19:4919:49, 25 March 2024 diff hist +108‎ Category:Other Chemotherapy and Cancer Drugs ‎No edit summary
• 19:4919:49, 25 March 2024 diff hist +135‎ Template:TreatmentInfo ‎No edit summary
• 19:4519:45, 25 March 2024 diff hist +4‎ Category:Nutraceuticals ‎ →‎List of Nutraceutical Treatments
• 19:4419:44, 25 March 2024 diff hist 0‎ Template:TreatmentInfo ‎No edit summary
• 19:4319:43, 25 March 2024 diff hist +27‎ Template:TreatmentInfo ‎No edit summary
• 19:3819:38, 25 March 2024 diff hist +20‎ N Property:Usefulness Rating ‎ Created page with "Has type::Number" current
• 19:3819:38, 25 March 2024 diff hist 0‎ Category:Nutraceuticals ‎ →‎List of Nutraceutical Treatments
• 19:1619:16, 25 March 2024 diff hist 0‎ Category:Other Chemotherapy and Cancer Drugs ‎No edit summary
• 19:1619:16, 25 March 2024 diff hist 0‎ Category:Other Chemotherapy and Cancer Drugs ‎No edit summary
• 19:1519:15, 25 March 2024 diff hist +13‎ Category:Other Chemotherapy and Cancer Drugs ‎No edit summary
• 19:1419:14, 25 March 2024 diff hist −679‎ Category:Other Chemotherapy and Cancer Drugs ‎No edit summary
• 19:1219:12, 25 March 2024 diff hist 0‎ Category:Other Chemotherapy and Cancer Drugs ‎No edit summary
• 19:1219:12, 25 March 2024 diff hist 0‎ Category:Other Chemotherapy and Cancer Drugs ‎No edit summary

24 March 2024

• 05:5305:53, 24 March 2024 diff hist +20‎ N Property:Usefulness rating ‎ Created page with "Has type::Number" current
• 05:5005:50, 24 March 2024 diff hist +42‎ Category:Highly Useful Treatments ‎ →‎Highly Useful Treatments
• 05:4805:48, 24 March 2024 diff hist −27‎ Category:Highly Useful Treatments ‎ →‎Highly Useful Treatments
• 05:4705:47, 24 March 2024 diff hist −23‎ Category:Highly Useful Treatments ‎ →‎Highly Useful Treatments
• 05:4405:44, 24 March 2024 diff hist −118‎ Category:Highly Useful Treatments ‎No edit summary
• 05:4405:44, 24 March 2024 diff hist +239‎ Main Page ‎No edit summary
• 05:4205:42, 24 March 2024 diff hist +482‎ N Category:Highly Useful Treatments ‎ Created page with "==Highly Useful Treatments== This page lists all treatments within the wiki that have been rated with a usefulness of 4 or 5, indicating promising or highly effective options based on current research and clinical trials. {{#ask: Category:Treatment Usefulness rating::4 OR Usefulness rating::5 |?Has treatment name=Name |?Usefulness rating |?Clinical trial phase=Phase |format=table |link=all |headers=show |searchlabel=View more treatments |class=wikitable sort..."
• 05:3405:34, 24 March 2024 diff hist −81‎ VT-122 ‎No edit summary
• 05:3205:32, 24 March 2024 diff hist +1,638‎ N VT-122 ‎ Created page with "{{TreatmentInfo |drug_name=VT-122 (Propranolol and Etodolac combination) |FDA_approval=No (VT-122 is an investigational combination of repurposed drugs; Propranolol and Etodolac are FDA-approved for other conditions) |used_for=Investigational use in cancer treatment, specifically targeting cachexia in non-small cell lung cancer, hepatocellular carcinoma, and potentially glioblastoma |clinical_trial_phase=Phase 2 (based on ongoing and completed trials for various cancer t..."
• 05:2705:27, 24 March 2024 diff hist +1,232‎ N Angiotensin-II Receptor Blockers (ARB) ‎ Created page with "{{TreatmentInfo |drug_name=Angiotensin-II Receptor Blockers (ARB) |FDA_approval=Yes (for hypertension; repurposed for cancer studies) |used_for=Investigational use in glioblastoma for potential reduction of vasogenic edema and steroid-sparing effects |clinical_trial_phase=Retrospective Studies |common_side_effects=Varies by specific ARB; can include dizziness, hypotension, and renal function alteration |OS_with=Not specified; studies have focused on steroid requirements..."
• 05:2305:23, 24 March 2024 diff hist +1,366‎ N Gleevec (Imatinib) ‎ Created page with "{{TreatmentInfo |drug_name=Gleevec (Imatinib) |FDA_approval=Yes (for chronic myelogenous leukemia and other cancers, not specifically approved for gliomas) |used_for=Investigational use in gliomas, specifically targeting overexpression of platelet-derived growth factor receptor (PDGFR) |clinical_trial_phase=Exploratory/Investigational (Specific phase for gliomas not provided) |common_side_effects=Varies; for leukemia treatment includes fluid retention, nausea, muscle cra..."
• 05:1905:19, 24 March 2024 diff hist 0‎ Main Page ‎No edit summary